Genecast is a cutting-edge biotech company specialized in developing medicines and advanced healthcare technologies with the focus on colon and lung cancer. Its products cover medicine guidance, treatment diagnosis, curative effect prediction and recurrence monitoring.

It is poised to become the leading company in circulating tumor DNA (ctDNA) liquid biopsy technique, which will change the way that cancer diagnosis and treatment are done.